Emphasizing the patient voice in health technology assessments

Sudesh Basra, Director, Market Access and Harrison Davis, Senior Consultant, Market Access | December 01, 2022

Hero image

Sudesh Basra and Harrison Davis explore the evolving role of the patient voice in market access, and the vital role of patients in health technology assessments.

The involvement of patient voice in demonstrating the value of treatments in healthcare is gaining in importance. While gaining patient insights is not a new topic for biopharmaceutical teams, the body of literature on the role of patient centricity in health technology assessments (HTA) is growing. As access to healthcare information has become more democratized, empowered patients are turning to social media, websites, and forums to independently seek out healthcare information. This represents an opportunity to engage patients far earlier in clinical development, gaining crucial insights and data to support the HTA process while also building lasting relationships which span the duration of the product lifecycle.

However, global progress in the involvement of patients in HTA has been challenging. The time is ripe for pharmaceutical manufacturers to evaluate and evolve how they engage with patients, determining how and when to best incorporate patient perspectives during product development, and to discover how to use patient insights more effectively to articulate the value of their product within the HTA process.

The benefits of patient-centric product development

The value of new health technologies is multidimensional and not limited to clinical benefit and cost. As a result, showing the nuanced benefits of a therapy requires the capture of patient value beyond traditional patient-reported outcomes.

A patient-centric approach strengthens the value of a product across the whole development cycle. Pharmaceutical manufacturers are increasingly recognizing patients as “consumers” because their voices, preferences, and behaviors are crucial to determining how a product can address the clinical and disease burden, as well as unmet therapeutic needs.


Fill out the form below to read the full article.

How we use cookies

Cookies are files saved on your phone, tablet or computer when you visit a website.

We use cookies to store information about how you use the Fishawack Health website, such as the pages you visit.

For more information, check the cookie statement

Cookie settings

We use 4 types of cookies. You can choose which cookies you're happy for us to use.

Cookies that measure website use

We use Google Analytics to measure how you use the website so we can improve it based on user needs. We do not allow Google to use or share the data about how you use this site.

  • how you got to the site
  • the pages you visit on fishawack.com, and how long you spend on each page
  • what you click on while you're visiting the site

Cookies that help with our communications and marketing

These cookies may be set by third party websites and do things like measure how you view Vimeo videos that are on Fishawack.com.

Cookies that remember your settings

These cookies do things like remember your preferences and the choices you make, to personalize your experience of using the site.

Strictly necessary cookies

These essential cookies do things like remember your progress through a form (eg. Registering for new content alerts).

These cookies always need to be on.